Bio-Medical Applications Of Tennessee, Inc. in Centerville, Tennessee - Dialysis Center

Bio-Medical Applications Of Tennessee, Inc. is a medicare approved dialysis facility center in Centerville, Tennessee and it has 13 dialysis stations. It is located in Hickman county at 193 Brown Junction Road, Centerville, TN, 37033. You can reach out to the office of Bio-Medical Applications Of Tennessee, Inc. at (931) 729-0810. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Tennessee, Inc. has the following ownership type - Profit. It was first certified by medicare in August, 2008. The medicare id for this facility is 442675 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBio-Medical Applications Of Tennessee, Inc.
Location193 Brown Junction Road, Centerville, Tennessee
No. of Dialysis Stations 13
Medicare ID442675
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


193 Brown Junction Road, Centerville, Tennessee, 37033
(931) 729-0810

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Tennessee, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1447470513
Organization NameFresenius Medical Care Centerville
Doing Business AsBio-medical Applications Of Tennessee, Inc.
Address193 Brown Junction Lane Centerville, Tennessee, 37033
Phone Number(931) 729-0810

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data17
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL18

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center30
    Adult patient months included in Kt/V greater than or equal to 1.2218
    Percentage of adult patients getting regular hemodialysis at the center100
    Percentage of pediatric patients getting regular hemodialysis at the center
  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center7
    Adult patient months included in Kt/V greater than or equal to 1.771
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Tennessee, Inc. with elevated calcium levels.

Patients with hypercalcemia38
Hypercalcemia patient months310
Patients with Serumphosphor42
Patients with Serumphosphor less than 3.5 mg/dL7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL28
Patients with Serumphosphor from 4.6 to 5.5 mg/dL28
Patients with Serumphosphor from 5.6 to 7 mg/dL19
Patients with Serumphosphor greater than 7 mg/dL18

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 26
Patient months included in arterial venous fistula and catheter summaries 197
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment81
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer4

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary31
Hospitalization Rate in facility215.3 (As Expected)
Hospitalization Rate: Upper Confidence Limit403.6
Hospitalization Rate: Lower Confidence Limit120.7

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Tennessee, Inc. were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility27.5 (As Expected)
Readmission Rate: Upper Confidence Limit40.1
Readmission Rate: Lower Confidence Limit16.9

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Bio-Medical Applications Of Tennessee, Inc. get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility4.62 (Worse than Expected)
SIR: Upper Confidence Limit9.13
SIR: Lower Confidence Limit2.02

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Bio-Medical Applications Of Tennessee, Inc.'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 29
Transfusion Rate in facility64.9 (As Expected)
Transfusion Rate: Upper Confidence Limit180
Transfusion Rate: Lower Confidence Limit26.5

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Bio-Medical Applications Of Tennessee, Inc. lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary132
Mortality Rate in facility24.5 (As Expected)
Mortality Rate: Upper Confidence Limit35.4
Mortality Rate: Lower Confidence Limit16.3

Dialysis Facility in Centerville, TN

Bio-Medical Applications Of Tennessee, Inc.
Location: 193 Brown Junction Road, Centerville, Tennessee, 37033
Phone: (931) 729-0810

Medicare Program: Medicare is a federal government program which provides health insurance to people who are 65 or older. This program also covers certain younger people with disabilities (who receive Social Security Disability Insurance - SSDI), and people with End-Stage Renal Disease (permanent kidney failure requiring dialysis or a transplant, sometimes called ESRD.

Medicare Assignment: Assignment means that your doctor, provider, or supplier agrees (or is required by law) to accept the Medicare-approved amount as full payment for covered services. Most doctors, providers, and suppliers accept assignment, but you should always check to make sure. Participating providers have signed an agreement to accept assignment for all Medicare-covered services.

NPI Number: The National Provider Identifier (NPI) is a unique identification number for covered health care providers. The NPI must be used in lieu of legacy provider identifiers in the HIPAA standards transactions. Covered health care providers and all health plans and health care clearinghouses must use the NPIs in the administrative and financial transactions adopted under HIPAA (Health Insurance Portability and Accountability Act).

Our Data: Information on www.medicarelist.com is built using data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA). The information disclosed on the NPI Registry are FOIA-disclosable and are required to be disclosed under the FOIA and the eFOIA amendments to the FOIA. There is no way to 'opt out' or 'suppress' the NPPES record data for health care providers with active NPIs.